Linee Guida - Varie

El-Hajj Fuleihan G, Clines GA, Hu MI, et al.
Treatment of hypercalcemia of malignancy in adults: an Endocrine Society clinical practice guideline.
J Clin Endocrinol Metab 2023, dgac621 (free full text).


Giustina A, Bouillon R, Dawson-Hughes B, et al.
Vitamin D in the older population: a consensus statement.
Endocrine 2023, 79: 31–44 (free full text).


DeTora LM, Toroser D, Sykes A, et al.
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update.
Ann Intern Med 2022, 175: 1298-304.


Cusi K, et al.
American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings. Co-sponsored by the American Association for the Study of Liver Diseases (AASLD).
Endocr Pract 2022, 28: 528-62. (free full text)


US Preventive Services Task Force.
Statin use for the primary prevention of cardiovascular disease in adults.
JAMA 2022, 328: 746-53 (free full text).


Husebye ES, et al.
Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline.
Eur J Endocrinol 2022, 187: G1–21 (free full text).


FitzGerald JD, et al.
2020 American College of Rheumatology guideline for the management of gout.
Arthritis Care Res 2020, 72: 744–60. (free full text)


Couturier J, et al.
Canadian practice guidelines for the treatment of children and adolescents with eating disorders.
J Eating Dis 2020, 8: 4 (free full text).


Bennett BL, et al
Wilderness Medical Society Clinical Practice Guidelines for the Management of Exercise-Associated Hyponatremia: 2019 Update.
Wildern Envirom Med 2020, 31: 50-62 (free full text).


Hiroshi A, et al.
Management of immune-related adverse events in endocrine organs induced by immune checkpoint inhibitors: clinical guidelines of the Japan Endocrine Society.
Endocr J 2019, 66: 581-6 (free full text).


Van Spronsen FJ, van Wegberg AMJ, Ahring K, et al.
Key European guidelines for the diagnosis and management of patients with phenylketonuria.
Lancet Diabetes Endocrinol 2017, 5: 743-56 (free full text).


Roman CJ, Cifu AS, Stein SL.
Management of Acne Vulgaris.
JAMA 2016, 316: 1402-3.


Qaseem A, McLean RM, Starkey M, Forciea MA.
Diagnosis of acute gout: a clinical practice guideline from the American College of Physicians.
Ann Intern Med 2106, doi:10.7326/M16-0569 (free full text).


Qaseem A, Harris RP, Forciea MA.
Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians.
Ann Intern Med 2016, doi:10.7326/M16-0570 (free full text).


Toplak H, Stauber R, Sourij H.
European Association for the Study of the Liver (EASL) & European Association for the Study of Diabetes (EASD) & European Association for the Study of Obesity (EASO).
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease.
Diabetologia 2016, 59: 1121–40 (free full text).


European Medicines Agency.
Guide to information on human medicines evaluated by EMA. What the Agency publishes and when.
10 May 2016 EMA/515416/2015 (free full text).


Spasovski G, Vanholder R, Allolio B, et al
Clinical practice guideline on diagnosis and treatment of hyponatraemia.
Eur J Endocrinol 2014, 170: G1–47 (free full text).